Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT
Document Type and Number:
WIPO Patent Application WO/2021/064137
Kind Code:
A3
Abstract:
The present invention relates to novel B7H6/CD3 binding proteins. The invention also relates to nucleic acids encoding such proteins; to methods for preparing such proteins; to host cells expressing or capable of expressing such proteins; to compositions comprising such proteins; and to uses of such proteins or such compositions, in particular for therapeutic purposes in the field of cancer diseases.

Inventors:
HIPP SUSANNE (DE)
ADAM PAUL (DE)
DZIEGELEWSKI MICHAEL (US)
GANESAN RAJKUMAR (US)
GORMAN PHILIP NICHOLAS (US)
GUPTA PANKAJ (US)
GUPTA PRIYANKA (US)
LASARO MARCIO (US)
SCHEER JUSTIN M (US)
VOYNOV VLADIMIR H (US)
Application Number:
PCT/EP2020/077586
Publication Date:
May 14, 2021
Filing Date:
October 01, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BOEHRINGER INGELHEIM INT (DE)
International Classes:
C07K16/28; A61P35/00
Domestic Patent References:
WO2017181001A12017-10-19
WO2013169691A12013-11-14
WO2012162067A22012-11-29
Other References:
ANONYMOUS: "mab10162: Human/Cynomolgus Monkey B7-H6 Antibody", R&D SYSTEMS PRODUCT CATALOG, 28 May 2019 (2019-05-28), pages 1 - 2, XP055683034, Retrieved from the Internet [retrieved on 20200406]
CAMERON S. BRANDT ET AL: "IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 163, no. 7, 15 June 2009 (2009-06-15), US, pages 4041 - 1503, XP055276540, ISSN: 0022-1007, DOI: 10.1084/jem.20090681
Attorney, Agent or Firm:
SIMON, Elke Anna Maria et al. (DE)
Download PDF: